Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
ABSTRACT HBsAg and HBeAg have gained traction as biomarkers of control and clearance during chronic hepatitis B virus infection (CHB). Improved understanding of the clearance correlates of these proteins could help inform improvements in patient-stratified care and advance insights into the underlyi...
Guardado en:
Autores principales: | Louise O. Downs, David A. Smith, Sheila F. Lumley, Meha Patel, Anna L. McNaughton, Jolynne Mokaya, M. Azim Ansari, Hizni Salih, Kinga A. Várnai, Oliver Freeman, Sarah Cripps, Jane Phillips, Jane Collier, Kerrie Woods, Keith Channon, Jim Davies, Eleanor Barnes, Katie Jeffery, Philippa C. Matthews |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a37f4cf6e4142c29019029dd957b26a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
por: Chen-Hsuan Wu, et al.
Publicado: (2017) -
Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
por: Gao F, et al.
Publicado: (2021) -
Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Yan-Wei Zhong, et al.
Publicado: (2021) -
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection
por: Sarah Kadelka, et al.
Publicado: (2021) -
Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
por: Chih-Chien Yao, et al.
Publicado: (2017)